TP53 and cancer: To induce sustained proliferation, cancer cells rely on three main genetic drivers: (i) activation of oncogenes such as MYC, (ii) inactivation of tumor suppressors such as TP53 and RB1, and (iii) a mutator phenotype related to reduced replication fidelity such as DNA polymerase alterations [47].